Merck on Thursday said its first-quarter adjusted profit rose 7% as lower costs helped offset a 2% decline in sales, ...

Pharmaceuticals giant Merck & Company (MRK) has cut its full-year profit forecasts fearing a $200 million hit from President ...

Proquad is rarely a newsmaker from Merck’s earnings, but this time around, the U.S. has had a series of measles outbreaks.

Germany's Merck KGaA is nearing a roughly $3.5 billion deal for SpringWorks Therapeutics , the Wall Street Journal reported ...

Reports Q1 revenue $15.5B, consensus $15.33B. “Our company made strong progress to start the year, with increasing contributions from our newer ...

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid an escalating trade war between ...

Merck maintained its 2025 full-year revenue guidance of $64.1 billion to $65.6 billion, representing 1% to 3% growth excluding foreign exchange impacts. EPS guidance was adjusted to $8.82 to $8.97, ...

Merck cut its 2025 adjusted earnings projection to a range between $8.82 and $8.97 a share from a previous estimate of $8.88 to $9.03 a share. The new guidance includes a charge of roughly $200 ...

Announcing better-than-expected financials for Q1 2025, Merck (NYSE:MRK) lowered its full-year outlook for earnings to ...

Hasbro's ongoing shift toward its digital and licensed gaming business helped in attracting younger customers after its toy ...

(Reuters) -Bristol Myers Squibb reported better-than-expected first-quarter revenue on Thursday and raised its full-year ...